Overnight Health Care: Dems hit GOP with ObamaCare lawsuit vote | GOP seeks health care reboot after 2018 losses | House Dems aim for early victories on drug pricing | CDC declares lettuce e-coli outbreak over

Overnight Health Care: Dems hit GOP with ObamaCare lawsuit vote | GOP seeks health care reboot after 2018 losses | House Dems aim for early victories on drug pricing | CDC declares lettuce e-coli outbreak over
© Getty Images

Welcome to Wednesday's Overnight Health Care.

The government shutdown is well into its third week and shows no sign of ending.

While the Department of Health and Human Services is funded, the Food and Drug Administration is not, and the shutdown is starting to impact food safety.

On Capitol Hill, Democrats are again highlighting the ObamaCare lawsuit, and incoming Senate Finance Committee Chairman Chuck GrassleyCharles (Chuck) Ernest GrassleyOvernight Health Care: Senators seek CBO input on preventing surprise medical bills | Oversight panel seeks OxyContin documents | Pharmacy middlemen to testify on prices | Watchdog warns air ambulances can put patients at 'financial risk' Drug prices are a matter of life and death Senate panel to hear from pharmacy middlemen on drug prices MORE (R-Iowa) outlined his priorities on drug pricing.

We'll start with ObamaCare:  

 

Democrats force Republicans to vote (again) on ObamaCare lawsuit

The House on Wednesday passed a resolution backing the chamber's recent move to defend ObamaCare against a lawsuit filed by GOP states, giving Democrats another opportunity to hit Republicans on health care.

ADVERTISEMENT

GOP Reps. Brian FitzpatrickBrian K. FitzpatrickThe importance of moderate voters Overnight Health Care: CDC pushes for expanding HIV testing, treatment | Dem group launches ads attacking Trump on Medicare, Medicaid cuts | Hospitals, insurers spar over surprise bills | O'Rourke under pressure from left on Medicare for all Dem group launches ads attacking Trump's 'hypocrisy on Medicare and Medicaid cuts' MORE (Pa.), John KatkoJohn Michael KatkoThe importance of moderate voters Overnight Health Care: CDC pushes for expanding HIV testing, treatment | Dem group launches ads attacking Trump on Medicare, Medicaid cuts | Hospitals, insurers spar over surprise bills | O'Rourke under pressure from left on Medicare for all Dem group launches ads attacking Trump's 'hypocrisy on Medicare and Medicaid cuts' MORE (N.Y.) and Tom ReedThomas (Tom) W. ReedPush for ‘Medicare for all’ worries centrist Dems Lower refunds amplify calls to restore key tax deduction Drug pricing fight centers on insulin MORE (N.Y.) joined with 232 Democrats to support the measure, part of Democrats' strategy of keeping the focus on the health care law heading into 2020. The final vote tally was 235 to 192.

While the House voted on Friday to formally intervene in the lawsuit as part of a larger rules package, Democrats teed up Wednesday's resolution as a standalone measure designed to put Republicans on record with their opposition to the 2010 law.

Why it matters: Democrats filed a motion with the court to intervene Friday. But members wanted another chance to hit Republicans on the issue they think won them back the House. Democrats are trying to balance the need for substantial action on health care with political messaging.

What's next: Democrats have said they will introduce bills stabilizing ObamaCare and will hold hearings prying into the Trump administration's decision not to defend the law in court.

The Energy & Commerce Committee will also hold a hearing later this month on the impacts of the case.

More on today's vote here.

 

House Dems look to start with smaller wins on drug prices

Drug pricing is one of House Democrats' top priorities, but they're looking to start with some smaller, bipartisan moves before moving on to the sweeping, controversial items, Democratic sources say.

Early priorities:

  • The Creates Act, which cracks down on drug companies gaming the system to delay the introduction of cheaper generic competition. It's supported by many Republicans, including Sen. Chuck Grassley (R-Iowa), who will chair the Senate Finance Committee.
  • A bill to crack down on "pay for delay" deals in which drug companies pay generic competitors not to bring their drugs to market, putting off competition.

Down the road is the big one: Allowing Medicare to negotiate drug prices, a policy Democrats have long called for but which most Republicans oppose. (More on this below...)

The politics: Both President TrumpDonald John TrumpSenate GOP budget ignores Trump, cuts defense Trump says he'll nominate Stephen Moore to Fed White House: ISIS territory in Syria has been 100 percent eliminated MORE and House Democrats say they want to lower drug prices, making it a possible rare area of bipartisan agreement. But both sides could be wary of giving the other wins ahead of the 2020 election.

Progressives will also be pushing Democratic leaders to go bigger soon.

Read more here.

 

Grassley already put his foot down on Medicare Part D price negotiation

"I don't want to mess with the government negotiating prices with the private sector," Sen. Chuck Grassley (R-Iowa), the new chairman of the Senate Finance Committee, told reporters Wednesday.

He told a Democratic colleague on the committee it's "one place where we're going to completely disagree."

But he supports drug importation: Grassley and Sen. Amy KlobucharAmy Jean KlobucharAmy Poehler reveals which Dem candidates her 'Parks and Recreation' character might vote for Harris's stepkids call her 'Momala' Sanders joins striking workers at UCLA in first 2020 California visit MORE (D-Minn.) reintroduced bipartisan legislation Wednesday that would allow the importation of prescription drugs from Canada, a proposal that has some support among Republicans and Democrats but has been opposed by the pharmaceutical lobby.

More on that here.

 

Speaking of drug prices... something to watch on Thursday

Sen. Bernie SandersBernard (Bernie) SandersDemocratic Socialists of America endorses Sanders for president Trump on 2020 Dems skipping AIPAC: 'I think they're anti-Jewish' The Hill's Morning Report — Washington readies for Mueller end game MORE (I-Vt.), along with Reps. Elijah CummingsElijah Eugene CummingsOvernight Health Care: Senators seek CBO input on preventing surprise medical bills | Oversight panel seeks OxyContin documents | Pharmacy middlemen to testify on prices | Watchdog warns air ambulances can put patients at 'financial risk' Hillicon Valley: Kushner accused of using WhatsApp, personal email for official work | White House rejects request for Trump-Putin communications | Facebook left 'hundreds of millions' of passwords unsecured | Tech pressured to root out extremism Cummings says Ivanka Trump not preserving all official communications MORE (D-Md.), Peter WelchPeter Francis WelchDivisions emerge over House drug price bills Trump CFO Weisselberg emerges as key person of interest for Dems Cohen claims batter Trump MORE (D-Vt.) and others, all fierce opponents of the pharmaceutical industry, will unveil a bill on Thursday, which is sure to be far-reaching.

Late last year, Sanders and Rep. Ro KhannaRohit (Ro) KhannaClinton and Ocasio-Cortez joke about Kushner's alleged use of WhatsApp Overnight Defense: Senate breaks with Trump on Yemen war | Shanahan hit with ethics complaint over Boeing ties | Pentagon rolls out order to implement transgender ban | Dem chair throws cold water on Space Force budget Senate breaks with Trump on Saudi-led war in Yemen MORE (D-Calif.) introduced a drug pricing bill that would have ended a drugmaker's patent protections if the price for a medication were higher than in other developed countries. Generic competitors would then be able to enter the market to sell alternative versions of the drug at a lower price.

 

GOP seeks health care reboot after 2018 losses

Republicans lost big in the House last year largely on the issue of health care. And ObamaCare repeal is now off the table with a Democratic House. So where do they go now?

Whit Ayres, GOP pollster: "Health care is such a significant part of our economy and the challenges are growing so great with the retirement of the baby boomers and the disruption brought about by ObamaCare that you can't just cede a critically important issue to the other side."

Jim McLaughlin, another GOP pollster: "We should be the guys and gals that are putting up things that make health care more affordable and more accessible."

Watch Sen. Lamar AlexanderAndrew (Lamar) Lamar AlexanderGOP eager to exploit Dem court-packing fight Overnight Health Care: Senators seek CBO input on preventing surprise medical bills | Oversight panel seeks OxyContin documents | Pharmacy middlemen to testify on prices | Watchdog warns air ambulances can put patients at 'financial risk' Trump signs executive order on campus free speech MORE (R-Tenn.): "I'll be meeting with senators on reducing health care costs," Alexander told The Hill in a recent interview. "At a time when one-half of our health care spending is unnecessary, according to the experts, we ought to be able to agree in a bipartisan way to reduce that."

Read more here.

 

Some good news: CDC says romaine lettuce is safe

An outbreak of e-coli linked to romaine lettuce "appears to be over," federal health officials declared Wednesday.

According to the Centers for Disease Control and Prevention, there have been 62 cases across 16 states and the District of Columbia since the disease was first reported in October.

There were no deaths, but 25 people were hospitalized, including two people who developed a type of kidney failure.

"Contaminated lettuce that made people sick in this outbreak should no longer be available," the CDC said in a statement.

More on the end of the outbreak here.

 

More food safety news: Because of the shutdown, FDA has halted most of its food inspections

The Food and Drug Administration (FDA) says it has suspended all routine domestic food facility inspections amid the partial government shutdown.

FDA Commissioner Scott Gottlieb told The Washington Post that he is putting together a plan to resume inspections of facilities that are deemed "high-risk."

The agency, which oversees the majority of the country's food supply, typically conducts roughly 160 routine inspections per week, the Post reported.

While food inspections of most of these facilities have halted due to the funding shortfall caused by the shutdown, Gottlieb says he is seeking to bring back enough workers to investigate high-risk facilities, which deal with sensitive foods such as seafood and cheese.

Read more here.

 

House Dems call on leadership to prioritize opioid epidemic

More than 60 House Democrats are urging leadership to make the opioid crisis a top priority in the new Congress.

The Democrats said Congress should dedicate more funding and staff to addressing the crisis, which killed 47,600 people in 2017.

ADVERTISEMENT

"At a time when our state and local partners are begging for federal assistance to combat the opioid crisis in their communities, Congress must answer the call through increased resources, creative solutions, and with more legislative staff," the Democrats wrote in a letter to Speaker Nancy PelosiNancy Patricia D'Alesandro PelosiThe Hill's Morning Report — Washington readies for Mueller end game Dem divisions deepen over approach to climate change 2020 Dems avoid this year's AIPAC conference MORE (Calif.) and Majority Leader Steny HoyerSteny Hamilton HoyerOvernight Defense: Top Marine warns border deployment could hurt readiness | McSally aims for sexual assault reforms in defense bill | House to vote on measure opposing transgender ban | New warning over F-35 sale to Turkey House Dems unveil measure to reject anti-Israel boycotts House to vote on measure opposing transgender military ban MORE (Md.). "Dedicated staff across House committees capable of analyzing both the larger federal need and specifics from states and districts is necessary at this point."

More on their letter here.

 

What we're reading

Bill de Blasio's plan to guarantee health care for every New Yorker, explained (Vox.com)

New Ebola-like virus is discovered in China (Stat News)

Science hinted that cancer patients could take less of a $148,000-a-year drug. Its maker tripled the price of a pill. (Washington Post)

 

State by state

New Wisconsin governor to change state's position on Obamacare lawsuit (Wisconsin Public Radio)

Democrats urge Florida governor DeSantis to expand Medicaid (Tampa Bay Times)

Different Medicaid expansion plans offered at Montana Legislature (KPAX)

 

From The Hill's op-ed page

The flu is a far greater threat than anything carried by people crossing the southern border